247 related articles for article (PubMed ID: 27177638)
1. Virologic Cure of Hepatitis C: Impact on Hepatic Fibrosis and Patient Outcomes.
Gonzalez HC; Duarte-Rojo A
Curr Gastroenterol Rep; 2016 Jul; 18(7):32. PubMed ID: 27177638
[TBL] [Abstract][Full Text] [Related]
2. American Gastroenterological Association Institute Clinical Practice Update-Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection.
Jacobson IM; Lim JK; Fried MW
Gastroenterology; 2017 May; 152(6):1578-1587. PubMed ID: 28344022
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of patients with chronic hepatitis C treated with α-interferon and ribavirin antiviral therapy: clinical and fibrosis impact of treatment response.
Cordero-Ruiz P; Carmona-Soria I; Rodríguez-Téllez M; Caunedo-Alvarez A; Quezada-Pacheco RH; Flores-Cucho A; Romero-Gómez M; Vilches-Arenas Á
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):792-799. PubMed ID: 28445251
[TBL] [Abstract][Full Text] [Related]
4. Achieving sustained virological response: what's the impact on further hepatitis C virus-related disease?
van der Meer AJ
Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):559-66. PubMed ID: 25579804
[TBL] [Abstract][Full Text] [Related]
5. Management of the patient with SVR.
Terrault NA; Hassanein TI
J Hepatol; 2016 Oct; 65(1 Suppl):S120-S129. PubMed ID: 27641982
[TBL] [Abstract][Full Text] [Related]
6. Hepatic benefits of HCV cure.
Calvaruso V; Craxì A
J Hepatol; 2020 Dec; 73(6):1548-1556. PubMed ID: 32777323
[TBL] [Abstract][Full Text] [Related]
7. Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C.
Jung CH; Um SH; Kim TH; Yim SY; Suh SJ; Yim HJ; Seo YS; Choi HS; Chun HJ
Gut Liver; 2016 Sep; 10(5):808-17. PubMed ID: 27114417
[TBL] [Abstract][Full Text] [Related]
8. Should surveillance for liver cancer be modified in hepatitis C patients after treatment-related cirrhosis regression?
D'Ambrosio R; Colombo M
Liver Int; 2016 Jun; 36(6):783-90. PubMed ID: 26936383
[TBL] [Abstract][Full Text] [Related]
9. Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective study.
Papastergiou V; Stampori M; Lisgos P; Pselas C; Prodromidou K; Karatapanis S
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):798-805. PubMed ID: 23395996
[TBL] [Abstract][Full Text] [Related]
10. Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study.
Colussi G; Donnini D; Brizzi RF; Maier S; Valenti L; Catena C; Cavarape A; Sechi LA; Soardo G
World J Gastroenterol; 2019 Oct; 25(40):6094-6106. PubMed ID: 31686765
[TBL] [Abstract][Full Text] [Related]
11. Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment.
Kozbial K; Moser S; Al-Zoairy R; Schwarzer R; Datz C; Stauber R; Laferl H; Strasser M; Beinhardt S; Stättermayer AF; Gschwantler M; Zoller H; Maieron A; Graziadei I; Trauner M; Steindl-Munda P; Hofer H; Ferenci P
Liver Int; 2018 Jun; 38(6):1028-1035. PubMed ID: 29136329
[TBL] [Abstract][Full Text] [Related]
12. Impact of hepatitis C oral therapy in portal hypertension.
Libânio D; Marinho RT
World J Gastroenterol; 2017 Jul; 23(26):4669-4674. PubMed ID: 28765688
[TBL] [Abstract][Full Text] [Related]
13. Survival benefits of interferon-based therapy in patients with recurrent hepatitis C after orthotopic liver transplantation.
Zanaga LP; Vigani AG; Angerami RN; Giorgetti A; Escanhoela CA; Ataíde EC; Boin IF; Stucchi RS
Braz J Med Biol Res; 2017 Jan; 50(1):e5540. PubMed ID: 28076451
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients.
Lybeck C; Brenndörfer ED; Sällberg M; Montgomery SM; Aleman S; Duberg AS
Eur J Gastroenterol Hepatol; 2019 Apr; 31(4):506-513. PubMed ID: 30461522
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C: Does Successful Treatment Alter the Natural History and Quality of Life?
Gonzalez HC; Gordon SC
Gastroenterol Clin North Am; 2020 Jun; 49(2):301-314. PubMed ID: 32389364
[TBL] [Abstract][Full Text] [Related]
16. Managing hepatitis C in patients with the complications of cirrhosis.
Mücke MM; Mücke VT; Lange CM; Zeuzem S
Liver Int; 2018 Feb; 38 Suppl 1():14-20. PubMed ID: 29427491
[TBL] [Abstract][Full Text] [Related]
17. Effects of a sustained virologic response on outcomes of patients with chronic hepatitis C.
Ng V; Saab S
Clin Gastroenterol Hepatol; 2011 Nov; 9(11):923-30. PubMed ID: 21699815
[TBL] [Abstract][Full Text] [Related]
18. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.
Butt AA; Yan P; Bonilla H; Abou-Samra AB; Shaikh OS; Simon TG; Chung RT; Rogal SS;
Hepatology; 2015 Aug; 62(2):365-74. PubMed ID: 25847403
[TBL] [Abstract][Full Text] [Related]
19. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.
van der Meer AJ; Veldt BJ; Feld JJ; Wedemeyer H; Dufour JF; Lammert F; Duarte-Rojo A; Heathcote EJ; Manns MP; Kuske L; Zeuzem S; Hofmann WP; de Knegt RJ; Hansen BE; Janssen HL
JAMA; 2012 Dec; 308(24):2584-93. PubMed ID: 23268517
[TBL] [Abstract][Full Text] [Related]
20. Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis.
Cheinquer N; Cheinquer H; Wolff FH; Coelho-Borges S
Braz J Infect Dis; 2010; 14(5):457-61. PubMed ID: 21221473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
